New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Novartis AG

NVS

Healthcare Drug Manufacturers General

Novartis AG’s revenue for fiscal 2025 (year ended December 2025) was $56.7 billion, up 9.57% from fiscal 2024.

Revenue
+4.67%
EPS
−68.8%
Free cash flow
−17.8%
Total debt
+53.9%

Quarter to September 2026, against a year earlier

151.63 0.42 +0.28%
Market cap
$277.7B
P/E
28.8×
Fwd P/E FY26e
24.0×
Dividend yield
3.13%
F-score
8/9
ROIC
12.1%
Net debt / EBITDA
1.0×
Payout ratio
0.9×

What it owns vs. what it owes Q3 FY2026, Sep 30, 2026

It owes $37.4B more in debt than it holds in cash and short-term investments. Debt has risen from $33.5B to $46.3B since Q4 FY25. Shareholders’ equity is 32.1% of the balance sheet. What is a balance sheet?

Sep 30, 2026 · total $117.1B

Owns

$88.4BLong-term assets
$19.8BOther short-term assets
$9.0BCash & short-term investments

Funded by

$37.6BShareholders’ equity
$33.2BOther liabilities
$46.3BDebt

Debt is 39.6% of the total; shareholders’ equity 32.1%.

Net debt rose from 20% of assets to 32% since Q4 FY25.

Total assetsNet debt (debt less cash)Net debt ÷ assets (right axis)
Assets and net debt, four quarters
Q4 FY25Q1 FY26Q2 FY26Q3 FY26
Total assets$110.9B$118.5B$122.0B$117.1B
Net debt (debt less cash)$21.9B$38.1B$39.4B$37.4B
Net debt ÷ assets (right axis)19.8%32.1%32.3%31.9%
Older periods Dec '25 Mar '26 Jun '26 Sep '26
Cash and Short Term Investments

+8 more quarters

11,590.00 6,977.00 7,690.00 8,975.00
Receivables
9,142.00 9,602.00 9,854.00 9,963.00
Inventory
6,269.00 6,286.00 6,220.00 6,104.00
Other current assets
3,459.00 3,742.00 3,587.00 3,705.00
Total current assets
30,460.00 26,607.00 27,351.00 28,747.00
Property, Plant, Equpment (Net)
10,782.00 10,654.00 10,685.00 10,622.00
Long-Term Investments
98.00 100.00 2,371.00 63.00
Goodwill and Intangible Assets (Total)
54,978.00 67,028.00 68,841.00 67,002.00
Long Term Assets (Tax, Deferred)
5,438.00 5,247.00 5,277.00 5,346.00
Long-term assets (Other)
7,623.00 7,312.00 5,926.00 3,720.00
Total non-current assets
80,489.00 91,925.00 94,682.00 88,402.00
Total Assets
110,949.00 118,532.00 122,033.00 117,149.00
Accounts Payable
4,456.00 4,322.00 4,258.00 4,243.00
Current Part of Debt
5,602.00 7,617.00 9,588.00 9,650.00
Current Part of Taxes to Pay
1,969.00 1,807.00 2,312.00 2,652.00
Other current liabilities
14,988.00 17,357.00 15,316.00 15,702.00
Total current liabilities
27,278.00 31,374.00 31,748.00 32,525.00
Long Term Debt (Total)
27,935.00 37,447.00 37,489.00 36,699.00
Long Term Tax Liability (Deferred)
3,397.00 5,104.00 5,292.00 4,397.00
Non-current Liabilities (Other)
4,133.00 4,017.00 3,895.00 4,281.00
Total non-current liabilities
37,122.00 48,231.00 48,339.00 47,060.00
Total liabilities
64,400.00 79,605.00 80,087.00 79,585.00
Common Stock (Net)
766.00 736.00 736.00 736.00
Retained Earnings
45,414.00 37,823.00 40,855.00 36,546.00
Treasury Stock
50.00 47.00 49.00 54.00
Common Equity (Total)
46,549.00 38,927.00 41,946.00 37,564.00
Shareholders Equity (Total)
46,549.00 38,927.00 41,946.00 37,564.00
Shareholders Equity and Liabilities (Total)
110,949.00 118,532.00 122,033.00 117,149.00
Shares (Common)
1,908.15 — 1,900.70 —
Shareholders Equity (Tangible)
(8,429.00) (28,101.00) (26,895.00) (29,438.00)
Net Debt
21,947.00 38,087.00 39,387.00 37,374.00
Total Debt
33,537.00 45,064.00 47,077.00 46,349.00

Fold the line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 18, 2026